Fixed drug eruption caused by piperacillin-tazobactam.
作者信息
Santosa A, Teo B W, Shek L P C
机构信息
Division of Rheumatology, Department of Medicine, National University Health System, Singapore.
出版信息
J Investig Allergol Clin Immunol. 2013;23(2):132-3.
PMID:23654084
Abstract
摘要
相似文献
1
Fixed drug eruption caused by piperacillin-tazobactam.
J Investig Allergol Clin Immunol. 2013;23(2):132-3.
2
Acute generalized exanthematous pustulosis caused by piperacillin/tazobactam.
J Am Acad Dermatol. 2005 Apr;52(4):732-3. doi: 10.1016/j.jaad.2004.08.030.
3
Piperacillin/tazobactam--induced petechial rash.
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1345-6. doi: 10.1345/aph.1P247. Epub 2010 Jun 22.
4
A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review.
Eur J Dermatol. 2017 Feb 1;27(1):88-89. doi: 10.1684/ejd.2016.2883.
5
Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.
Dermatol Online J. 2018 Apr 15;24(4):13030/qt8cr714g5.
6
Acute generalized exanthematous pustulosis: a rare clinical entity with use of piperacillin/tazobactam.
Am J Ther. 2009 Nov-Dec;16(6):591-2. doi: 10.1097/MJT.0b013e31818d5f6d.
7
A vesiculobullous eruption in a hospitalized patient. Diagnosis: Drug-induced linear IgA bullous dermatosis (LAD) with eosinophils.
Arch Dermatol. 2011 Dec;147(12):1443, 1448. doi: 10.1001/archderm.147.12.1443-c.
8
Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
Ann Pharmacother. 2004 Jun;38(6):996-8. doi: 10.1345/aph.1D378. Epub 2004 Apr 27.
9
Pustular eruption in the ICU.
Am J Med. 2012 Aug;125(8):758-60. doi: 10.1016/j.amjmed.2012.04.029.
10
Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
Br J Dermatol. 2016 Nov;175(5):1106-1108. doi: 10.1111/bjd.14069. Epub 2016 Aug 23.
Zotero 插件